ATE527997T1 - Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien - Google Patents

Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien

Info

Publication number
ATE527997T1
ATE527997T1 AT07734240T AT07734240T ATE527997T1 AT E527997 T1 ATE527997 T1 AT E527997T1 AT 07734240 T AT07734240 T AT 07734240T AT 07734240 T AT07734240 T AT 07734240T AT E527997 T1 ATE527997 T1 AT E527997T1
Authority
AT
Austria
Prior art keywords
aminapthone
arteriopathies
medication
treatment
production
Prior art date
Application number
AT07734240T
Other languages
English (en)
Inventor
Raffaella Scorza
Original Assignee
Fond Irccs Ca Granda Ospedale Maggiore Policlinico
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fond Irccs Ca Granda Ospedale Maggiore Policlinico filed Critical Fond Irccs Ca Granda Ospedale Maggiore Policlinico
Application granted granted Critical
Publication of ATE527997T1 publication Critical patent/ATE527997T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07734240T 2006-04-11 2007-04-10 Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien ATE527997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT000712A ITMI20060712A1 (it) 2006-04-11 2006-04-11 Uso di aminaftone per la preparazione di un medicamento per il trattamento delle arteriopatie
PCT/IB2007/000921 WO2007116297A2 (en) 2006-04-11 2007-04-10 Use of aminapthone for the preparation of a medicament for treating arteriophaties

Publications (1)

Publication Number Publication Date
ATE527997T1 true ATE527997T1 (de) 2011-10-15

Family

ID=38480588

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07734240T ATE527997T1 (de) 2006-04-11 2007-04-10 Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien

Country Status (10)

Country Link
US (2) US8202903B2 (de)
EP (2) EP2004173B1 (de)
JP (1) JP2009533414A (de)
AT (1) ATE527997T1 (de)
BR (1) BRPI0711841A2 (de)
CA (1) CA2648751C (de)
ES (2) ES2374659T3 (de)
IT (1) ITMI20060712A1 (de)
PT (2) PT2004173E (de)
WO (1) WO2007116297A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1400389B1 (it) * 2010-05-27 2013-05-31 Baldacci Lab Spa Aminaftone per uso nel trattamento e/o nella prevenzione dell'emicrania
US9753909B2 (en) 2012-09-07 2017-09-05 Splunk, Inc. Advanced field extractor with multiple positive examples
US9152929B2 (en) 2013-01-23 2015-10-06 Splunk Inc. Real time display of statistics and values for selected regular expressions

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252224B (de) * 1964-10-05 1967-02-10 Finanz Kompensations Anst Verfahren zur Herstellung von neuen 2-Aminobenzoyloxy-naphthohydrochinonen
ES456574A1 (es) 1977-03-07 1978-02-16 Rocador Sa Procedimiento de obtencion de pentametil-carbamato de quer- cetina.
IT1201149B (it) 1987-01-14 1989-01-27 Indena Spa Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche
US5648377A (en) 1993-12-21 1997-07-15 Indena S.P.A. Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals
IT1275955B1 (it) 1995-03-22 1997-10-24 Dompe Spa Formulazioni farmaceutiche in forma di gel tissotropico
WO2001089542A2 (en) 2000-05-25 2001-11-29 Pharmaton S.A. Composition for improving the cell protection comprising a lipophilic antioxidant and a hydrophilic antioxidant
JP2003238439A (ja) * 2002-02-13 2003-08-27 Yasuhiko Tabata 虚血治療剤
AU2003235931A1 (en) * 2002-05-13 2003-11-11 Takata Seiyaku Co., Ltd. Vintoperol-containing medicinal composition for transdermal administration
US7202222B2 (en) 2003-01-06 2007-04-10 National Bioscience Corporation Methods for treatment of obesity and effective fat loss promotion
JP4598593B2 (ja) * 2004-05-10 2010-12-15 晶岩 韓 虚血再灌流による微小循環障害の予防・治療用薬剤

Also Published As

Publication number Publication date
EP2335695B1 (de) 2014-08-20
PT2004173E (pt) 2012-01-11
BRPI0711841A2 (pt) 2011-12-13
WO2007116297A3 (en) 2008-01-10
US20090182045A1 (en) 2009-07-16
ITMI20060712A1 (it) 2007-10-12
PT2335695E (pt) 2014-10-29
JP2009533414A (ja) 2009-09-17
EP2004173B1 (de) 2011-10-12
CA2648751A1 (en) 2007-10-18
US20120022155A1 (en) 2012-01-26
EP2004173A2 (de) 2008-12-24
ES2374659T3 (es) 2012-02-20
US10028929B2 (en) 2018-07-24
CA2648751C (en) 2013-01-22
ES2519345T3 (es) 2014-11-06
WO2007116297A2 (en) 2007-10-18
US8202903B2 (en) 2012-06-19
EP2335695A1 (de) 2011-06-22

Similar Documents

Publication Publication Date Title
MX2010005631A (es) Nuevos compuestos de hidrocarburo ciclicos para el tratamiento de enfermedades.
ATE512661T1 (de) Verwendung eines betablockers zur herstellung eines arzneimittels zur behandlung von hämangiomen
CY1111454T1 (el) Παραγωγα φαινυλο-πυραζολιου ως συνδετες υποδοχεα μη στεροειδων γλυκοκορτικοειδων
UA85707C2 (ru) Бензоксазины для лечения заболеваний дыхательных путей
TW200604196A (en) New quinuclidine derivatives and pharmaceutical compositions comprising them
HK1097774A1 (en) Stable pharmaceutical composition comprising linezolid from iv
EA200801580A1 (ru) Новые производные пирониндола и способ их получения
ATE302774T1 (de) Arzneimittel enthaltend betamimetika und ein neues anticholinergikum
CY1115725T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων
MY146802A (en) Novel drugs for treating respiratory diseases
CY1114760T1 (el) Θεραπευτικη αγωγη αθηροσκληρωσης
ATE526015T1 (de) Arzneimittel sowie deren herstellung und verwendung bei der behandlung von schmerzhaften neuropathien
ATE455789T1 (de) Substituierte nonadepsipeptide
EA200900269A1 (ru) Лекарственные комбинации для лечения заболеваний дыхательных путей
ATE527997T1 (de) Verwendung von aminapthon zur herstellung eines medikaments zur behandlung von arteriopathien
ATE479423T1 (de) Vorrichtung für die topische anwendung des medizinischen ozons zur behandlung von erkrankungen der mundhöhle
WO2008023004A8 (de) Enantiomerenreine betaagonisten, verfahren zu deren herstellungen und deren verwendung als arzneimittel
ATE391710T1 (de) Substituierte azetidinverbindungen als cyclooxigenase-1-cyclooxygenase-2-inhibitoren und deren herstellung und verwendung als medikament
ATE424195T1 (de) Verwendung von 2-amino-1,3-propandiolderivaten zur herstellung eines medikaments zur behandlung von bestimmten schmerzen
ATE491443T1 (de) Verwendung des agomelatins zur herstellung eines medikamentes zur behandlung der bipolaren erkrankungen
ATE444754T1 (de) Verwendung von tyrosinkinase-inhibitoren zur behandlung inflammatorischer prozesse
DE602005000442D1 (de) Verwendung von alpha-1-Antitrypsin zur Herstellung eines Medikaments zur Behandlung von Fibromyalgie
DE602006019830D1 (de) Tetrahydro- und dihydrochinazolinone
ATE477820T1 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung bei der behandlung von adipositas- patienten
MX2007010841A (es) 8-pirrolidinobenzimidazoles biciclicos sustituidos, un metodo para su produccion y su uso como medicamentos.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 2004173

Country of ref document: EP